Login / Signup
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19.
Fasihul A Khan
Iain D Stewart
Laura Fabbri
Samuel Moss
Karen Robinson
Alan Robert Smyth
R Gisli Jenkins
Published in:
Thorax (2021)
CRD42020176375.
Keyphrases
</>
coronavirus disease
sars cov
rheumatoid arthritis
juvenile idiopathic arthritis
rheumatoid arthritis patients
respiratory syndrome coronavirus
disease activity
systemic lupus erythematosus